- Home
- WLKP vs VALN Comparison
WLKP vs VALN Comparison
Compare WLKP & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- VALN
- Stock Information
- Founded
- WLKP 2014
- VALN 2012
- Country
- WLKP United States
- VALN France
- Employees
- WLKP N/A
- VALN N/A
- Industry
- WLKP Major Chemicals
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WLKP Industrials
- VALN Health Care
- Exchange
- WLKP Nasdaq
- VALN Nasdaq
- Market Cap
- WLKP 741.1M
- VALN 777.9M
- IPO Year
- WLKP 2014
- VALN 2021
- Fundamental
- Price
- WLKP $21.00
- VALN $10.63
- Analyst Decision
- WLKP
- VALN Strong Buy
- Analyst Count
- WLKP 0
- VALN 4
- Target Price
- WLKP N/A
- VALN $15.75
- AVG Volume (30 Days)
- WLKP 50.5K
- VALN 78.2K
- Earning Date
- WLKP 11-04-2025
- VALN 11-06-2025
- Dividend Yield
- WLKP 8.99%
- VALN N/A
- EPS Growth
- WLKP N/A
- VALN N/A
- EPS
- WLKP 1.49
- VALN N/A
- Revenue
- WLKP $1,101,803,000.00
- VALN $230,566,060.00
- Revenue This Year
- WLKP $3.27
- VALN $15.69
- Revenue Next Year
- WLKP $13.98
- VALN $22.15
- P/E Ratio
- WLKP $14.04
- VALN N/A
- Revenue Growth
- WLKP N/A
- VALN 25.47
- 52 Week Low
- WLKP $20.63
- VALN $3.62
- 52 Week High
- WLKP $25.04
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- WLKP 41.69
- VALN 54.35
- Support Level
- WLKP $20.80
- VALN $9.70
- Resistance Level
- WLKP $21.45
- VALN $12.23
- Average True Range (ATR)
- WLKP 0.37
- VALN 0.44
- MACD
- WLKP 0.02
- VALN 0.05
- Stochastic Oscillator
- WLKP 35.92
- VALN 36.76
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.